New PTH test could Fine-Tune mineral balance in kidney dialysis
NCT ID NCT02859220
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a new method of measuring parathyroid hormone (PTH) can help doctors better manage calcium and phosphate levels in people on hemodialysis. About 80 patients with end-stage kidney disease will be randomly assigned to have their PTH measured either with the standard test or with a newer test that distinguishes between active and inactive PTH fragments. The goal is to see if the new test helps patients more easily meet international targets for calcium, phosphorus, and related minerals.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PTH 1-84 Complete (CAP) and ratio PTH 1-84/7-84 measurement
What this could lead to
If successful, this could improve how doctors adjust treatment for calcium and phosphate imbalances in dialysis patients, helping them meet health targets more easily.
What could go wrong
This is a small, early-stage study focused on testing a measurement method, not a treatment. The new test may not lead to better patient outcomes or may be too complex for routine use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nantes
Nantes, 44093, France